506U78 in Treating Patients With Refractory Hematologic Cancer

Clinical trial NCT00002970 · COMPLETED

Trial details

NCT number: NCT00002970
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Childhood Acute Lymphoblastic Leukemia

Start date: 1997-06-01
Primary completion: 2005-01-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.